Toronto Canada (PRWEB) January 30 2013 Cell-based assays or bioassays are important for establishing safety efficacy and stability profiles biopharmaceuticals. What?s more these assays must be sufficiently robust to meet international regulatory and USP guidelines for system suitability. These tools are crucial for drug product lot release and stability
Toronto, Canada (PRWEB) January 30, 2013
Cell-based assays, or bioassays, are important for establishing safety, efficacy and stability profiles biopharmaceuticals. What?s more, these assays must be sufficiently robust to meet international regulatory and USP guidelines for system suitability. These tools are crucial for drug product lot release and stability testing to support licensing for commercialization.
Generally, assays are designed to demonstrate the relative potency of a product by comparing the biological response with a control preparation (such as USP, WHO, or an in-house reference standard). These assays are an essential component of the characterization/validation process and can be used to select candidates; establish comparability; test process intermediates, formulations and stability/degradation; and to support product changes.
In this webinar, our expert, Dr. Peter Wunderli, will review a case study for a biological drug product. Dr. Wunderli will go over topics including: the re-development of the bioassay method for potency and an improved process for extracting the drug product from a carrier so that the potency of the final drug product could be reproducibly measured.
For more information about this event or to register, visit: http://xtks.in/xto561-event
Xtalks is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx'/>"/>
| Source: PRWeb Copyright?2012 Vocus, Inc. All rights reserved |
Related biology technology :
1. Gated STED -- developing the next generation of super-resolution microscopes
2. Elsevier Foundation Awards 2011 Grants to Advance Women in Science and Support Libraries in Developing Countries
3. Frost & Sullivan Recognizes iCubate for Developing the New Gold Standard Instrument in the PCR Market
4. CNIO researchers describe a new target for developing anti-angiogenic and anti-tumoral therapies
5. SRI International Researchers Developing Bioadhesive Gel to Protect Women from HIV and HSV Infections
6. Carnegie Mellons Jeffrey Hollinger Leads Research Team Developing New Tools To Ease Pain of Combat Injuries
7. Elsevier Offers Entire Collection of Journals and Books to Innovators in Developing Countries Through the Access to Research for Development and Innovation (ARDI) Program
8. Phalanx Biotech Group Reports Robust Revenue Growth in 2011
9. endpoint Adopts New Technology To Boast Most Robust IVR Validation Objective Evidence and Decrease IVR Build Timelines
10. New nanotech fiber: Robust handling, shocking performance
11. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
Ebates lotto Illinois Lottery texas lottery Dell Levis Fireman Ed
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.